100% of Customer Satisfaction in 2024
100% of Customer Satisfaction in 2024
We’re proud to share that in 2024, we achieved a 100% customer satisfaction rate, with an average score of 9.3 out of 10.
It’s important for us to establish a trustful and long-lasting relationship with our customers. That’s why we asked our customers to evaluate the quality of their collaboration with us throughout the 2024 studies. The results speak for themselves: 100% of respondents reported being fully satisfied with their experience working with ETAP-Lab and our laboratories.
Our clients value our expertise, the quality of our studies, and our flexibility. They particularly appreciate our dedicated teams, known for their attentiveness, responsiveness, and clear communication throughout every stage of the study.
We provide dedicated support and guide our clients every step of the way, advancing in vitro & in vivo preclinical studies – whether for new treatments, medical devices, pharmaceuticals or active compounds. Our flexible, human-scale organization allows us to provide tailored services across several fields: neurology, neurovascular research, cardiology, and dermatology.
Ready to start your next drug efficacy study? Get in touch today to discover how ETAP-Lab can help drive your success.
I want to start a study
To go further about ISO9001:v2015 certification:
In 2024, ETAP-Lab has successfully renewed its ISO9001:v2015 certification. This achievement underlines its commitment to providing exemplary preclinical research services. Robust quality management system developed over 10 years ago, backed by ISO9001 certification, ensures quality, reliability and customer satisfaction.
The certificate was granted by OFC until October 1, 2027 for its Quality Management System for consulting, advising and study expertise in the field of in vitro and in vivo preclinical research.
